Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Agenus Inc (NQ: AGEN ) 5.100 -0.380 (-6.93%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 363,269 Open 5.440 Bid (Size) 5.030 (3) Ask (Size) 5.250 (1) Prev. Close 5.480 Today's Range 5.060 - 5.470 52wk Range 0.4100 - 19.69 Shares Outstanding 348,875,959 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GitLab, Agenus, ZoomInfo, and Super Micro and Encourages Investors to Contact the Firm October 01, 2024 From Bragar Eagel & Squire Via GlobeNewswire Agenus Inc. Class Action Reminder - AGEN Stockholders with Large Losses They Should Contact Shareholder Rights Law Firm Robbins LLP for Information About the Agenus Inc. Class Action Lawsuit September 30, 2024 From Robbins LLP Via GlobeNewswire Performance YTD +537.34% +537.34% 1 Month +3.03% +3.03% 3 Month -64.29% -64.29% 6 Month +896.09% +896.09% 1 Year +385.71% +385.71% More News Read More AGENUS INC. (NASDAQ: AGEN) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Agenus Inc. Investors of Upcoming Deadline September 30, 2024 From Bernstein Liebhard LLP Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Allarity, Agenus, and New Fortress and Encourages Investors to Contact the Firm September 26, 2024 From Bragar Eagel & Squire Via GlobeNewswire Shareholder Rights Law Firm Robbins LLP Reminds AGEN Stockholders with Large Losses They Should Obtain Counsel to Seek Lead Plaintiff Status in the Agenus Inc. Class Action Lawsuit September 25, 2024 From Robbins LLP Via Business Wire ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Agenus Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AGEN September 23, 2024 From The Rosen Law Firm PA Via GlobeNewswire AGENUS INC. (NASDAQ: AGEN) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Agenus Inc. Investors of Upcoming Deadline September 23, 2024 From Bernstein Liebhard LLP Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GitLab, Agenus, New Fortress, and ZoomInfo and Encourages Investors to Contact the Firm September 22, 2024 From Bragar Eagel & Squire Via GlobeNewswire AGEN Class Action Notice: Robbins LLP Reminds Agenus Inc. Stockholders of Pending AGEN Class Action Lawsuit September 20, 2024 From Robbins LLP Via GlobeNewswire AGEN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Agenus Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! September 20, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire ROSEN, A LEADING LAW FIRM, Encourages Agenus Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AGEN September 20, 2024 From The Rosen Law Firm PA Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GitLab, Agenus, and ZoomInfo and Encourages Investors to Contact the Firm September 18, 2024 From Bragar Eagel & Squire Via GlobeNewswire GSK's Respiratory Syncytial Virus Vaccine Given Together With Shingles Shot Shows Non-Inferior Immune Response In Older Adults September 18, 2024 Via Benzinga Exposures Product Safety Agenus Inc. Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the AGEN Class Action Lawsuit September 17, 2024 From Robbins LLP Via Business Wire ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Agenus Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AGEN September 16, 2024 From The Rosen Law Firm PA Via GlobeNewswire AGENUS INC. (NASDAQ: AGEN) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Agenus Inc. Investors of Upcoming Deadline September 16, 2024 From Bernstein Liebhard LLP Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GitLab, Agenus, and ZoomInfo and Encourages Investors to Contact the Firm September 14, 2024 From Bragar Eagel & Squire Via GlobeNewswire Botensilimab/Balstilimab Clinical Responses in Refractory Sarcomas Presented at ESMO 2024 September 13, 2024 From Agenus Inc. Via Business Wire AGEN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Agenus Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! September 12, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire AGENUS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Agenus Inc. and Encourages Investors to Contact the Firm September 11, 2024 From Bragar Eagel & Squire Via GlobeNewswire Investor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against Agenus Inc. September 10, 2024 From Robbins LLP Via GlobeNewswire AGEN Investors Have Opportunity to Lead Agenus Inc. Securities Fraud Lawsuit with the Schall Law Firm September 09, 2024 From The Schall Law Firm Via Business Wire Rosen Law Firm Urges Agenus Inc. (NASDAQ: AGEN) Stockholders with Large Losses to Contact the Firm for Information About Their Rights September 09, 2024 From The Rosen Law Firm, P.A. Via Business Wire AGENUS INC. (NASDAQ: AGEN) INVESTOR ALERT: Investors With Large Losses in Agenus Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights September 09, 2024 From Bernstein Liebhard LLP Via GlobeNewswire Botensilimab/Balstilimab Clinical Activity in Refractory Sarcomas to be Presented in Oral Session at ESMO 2024 September 09, 2024 From Agenus Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.